-
Mashup Score: 11Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke - 3 year(s) ago
Background and Purpose— The TST trial (Treat Stroke to Target) evaluated the benefit of targeting a LDL (low-density lipoprotein) cholesterol of <70 mg/dL to reduce the risk of cardiovascular events
Source: StrokeCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2
Background: The TST trial (Treat Stroke to Target) showed the benefit of targeting a low-density lipoprotein cholesterol (LDL-C) concentration of <70 mg/dL in terms of reducing the risk of major card
Source: CirculationCategories: Cardiologists, Latest HeadlinesTweet-
Carotid Atherosclerosis Evolution When Targeting #LDLC below 70 mg/dL : data from #TST-PLUS https://t.co/pctACWTH25
-
-
Mashup Score: 2Evinacumab Lowers LDL Cholesterol in Refractory Hypercholesterolemia - Endocrinology Advisor - 3 year(s) ago
Evinacumab therapy reduced low-density lipoprotein cholesterol (LDL-c) concentrations by up to 50% in patients with refractory hypercholesterolemia.
Source: Endocrinology AdvisorCategories: Endocrinology, Latest HeadlinesTweet-
#Evinacumab therapy significantly reduced #LDLc concentrations by up to 50% among patients with refractory #hypercholesterolemia. https://t.co/is93bXLKrh
-
-
Mashup Score: 1Consistent LDL-C Lowering Reported With Twice-Yearly Inclisiran - Endocrinology Advisor - 4 year(s) ago
Treatment with twice-yearly inclisiran consistently reduced LDL-C levels over a period of 17 months, according to a post-hoc analysis of pooled data from the two phase 3 trials presented at the European Society of Cardiology Congress 2020.
Source: Endocrinology AdvisorCategories: Endocrinology, Latest HeadlinesTweet-
Treatment with twice-yearly inclisiran consistently reduced low-density #LDLC levels over a period of 17 months. https://t.co/qPlzQNJ2YL
-
-
Mashup Score: 1Lower Target for LDL-C Levels Reduces Risk for Cardiovascular Events After Stroke - Endocrinology Advisor - 4 year(s) ago
High-intensity statin treatment after ischemic stroke or transient ischemic attack is associated with a reduced risk for subsequent cardiovascular events.
Source: Endocrinology AdvisorCategories: Endocrinology, Latest HeadlinesTweet-
High-intensity #statin treatment to lower #LDLC target levels after ischemic #stroke or transient ischemic attack is associated with a reduced risk for subsequent cardiovascular events. https://t.co/FUU2R7DTw2 #endocrinology #endotwitter #endopath
-
-
Mashup Score: 4Coconut Oil Raises LDL, Does Not Improve Weight, Inflammation, or Blood Sugar in Review Clinical Trials - 4 year(s) ago
This Medical News article discusses a recent review of 17 clinical trials comparing the effects of coconut oil and other vegetable oils on cardiovascular disease risk factors.
Source: jamanetwork.comCategories: General Medicine Journals and SocietiesTweet-
Study finds #coconutoil raises #LDLC, does not improve weight, inflammation, or #bloodsugar, @jenabbasi reports https://t.co/NJkW2SRnIm
-
-
Mashup Score: 0
The American College of Cardiology’s 69th Annual Scientific Session and Expo, together with the World Heart Federation World Congress of Cardiology, is the premier event in the cardiology world. While this year’s session was scheduled to be held March 28-30 in Chicago, the meeting will now be providing the latest information and sharing insights virtually.
Source: www.mdmag.comCategories: General Medicine NewsTweet-
Discussing how approval of bempedoic acid impacts the role of PCSK9 inhibitors for lowering LDL-C with Dr. Bhatt, of @BrighamWomens. #LDLC #cholesterol #ACC20/#WCCardio https://t.co/XstAfpMSho
-
Benefit of Targeting a #LDLC <70 mg/dL During 5 Years After Ischemic #Stroke #TST https://t.co/xpzSG5wjOy